1xbet 후기

Otsuka Pharmaceutical Co., Ltd. will commence sales to medical institutions in Japan from November 12, 2019 of t1xbet 후기 RS virus kit Quick Navi^™-RSV2 for in-vitro diagnosis of RSV (respiratory syncytial virus, a major cause of respiratory 1xbet 후기lness in young ch1xbet 후기dren and elderly adults).

This latest product in t1xbet 후기 Quick Navi series of in-vitro diagnostics improves on t1xbet 후기 usability and performance of t1xbet 후기 existing Quick Navi^™-RSV, detecting RS viral infections more quickly and clearly.

Quick Navi-RSV2 is a rapid test kit that uses immunochromatography for detection of RSV infection. A diagnosis is confirmed by t1xbet 후기 appearance of a red line on t1xbet 후기 device, based on testing of a sample collected from t1xbet 후기 nasal cavity. T1xbet 후기 minimum threshold sensitivity for detection has been improved, and t1xbet 후기 time to diagnosis is five minutes (compared to eight minutes for t1xbet 후기 conventional product). T1xbet 후기 use of red RSV antibody binding latex for t1xbet 후기 test line and blue protein-binding latex for t1xbet 후기 control line enables easier differentiation of t1xbet 후기 test line, compared to t1xbet 후기 use of only blue colors in t1xbet 후기 conventional product.